BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 15860261)

  • 1. Calcidiol and prostate cancer.
    Tuohimaa P; Golovko O; Kalueff A; Nazarova N; Qiao S; Syvälä H; Talonpoika R; Lou YR
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):183-90. PubMed ID: 15860261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D, aging, and cancer.
    Tuohimaa P
    Nutr Rev; 2008 Oct; 66(10 Suppl 2):S147-52. PubMed ID: 18844842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of vitamin D status: background, clinical use, and methodologies.
    Hart GR; Furniss JL; Laurie D; Durham SK
    Clin Lab; 2006; 52(7-8):335-43. PubMed ID: 16955631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D-induced up-regulation of tumour necrosis factor alpha (TNF-alpha) in prostate cancer cells.
    Golovko O; Nazarova N; Tuohimaa P
    Life Sci; 2005 Jun; 77(5):562-77. PubMed ID: 15904673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D and aging.
    Tuohimaa P
    J Steroid Biochem Mol Biol; 2009 Mar; 114(1-2):78-84. PubMed ID: 19444937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seasonal and geographical variations in lung cancer prognosis in Norway. Does Vitamin D from the sun play a role?
    Porojnicu AC; Robsahm TE; Dahlback A; Berg JP; Christiani D; Bruland OS; Moan J
    Lung Cancer; 2007 Mar; 55(3):263-70. PubMed ID: 17207891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular activity of 1,25-dihydroxyvitamin D3 in primary cultures of human prostatic epithelial cells revealed by cDNA microarray analysis.
    Peehl DM; Shinghal R; Nonn L; Seto E; Krishnan AV; Brooks JD; Feldman D
    J Steroid Biochem Mol Biol; 2004 Oct; 92(3):131-41. PubMed ID: 15555907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanistic and pharmacodynamic studies of a 25-hydroxyvitamin D3 derivative in prostate cancer cells.
    Lambert JR; Young CD; Persons KS; Ray R
    Biochem Biophys Res Commun; 2007 Sep; 361(1):189-95. PubMed ID: 17658477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium intake and vitamin D metabolism and action, in healthy conditions and in prostate cancer.
    Bonjour JP; Chevalley T; Fardellone P
    Br J Nutr; 2007 Apr; 97(4):611-6. PubMed ID: 17349071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D and the epidemiology of prostate cancer.
    Schwartz GG
    Semin Dial; 2005; 18(4):276-89. PubMed ID: 16076349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of cholesterol 25-hydroxylase expression by vitamin D3 metabolites in human prostate stromal cells.
    Wang JH; Tuohimaa P
    Biochem Biophys Res Commun; 2006 Jun; 345(2):720-5. PubMed ID: 16696936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal serum calcidiol concentration for cancer prevention.
    Tuohimaa P; Lou YR
    Anticancer Res; 2012 Jan; 32(1):373-81. PubMed ID: 22213329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of aromatase and 5alpha-reductase by 25-hydroxyvitamin D(3), 1alpha,25-dihydroxyvitamin D(3), dexamethasone and progesterone in prostate cancer cells.
    Lou YR; Murtola T; Tuohimaa P
    J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):151-7. PubMed ID: 15862960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Better functional mobility in community-dwelling elderly is related to D-hormone serum levels and to daily calcium intake.
    Dukas L; Staehelin HB; Schacht E; Bischoff HA
    J Nutr Health Aging; 2005; 9(5):347-51. PubMed ID: 16222401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of 25(OH) vitamin D (calcidiol) deficiency at time of renal transplantation: a prospective study.
    Sadlier DM; Magee CC
    Clin Transplant; 2007; 21(6):683-8. PubMed ID: 17988259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased expression of corepressors in aggressive androgen-independent prostate cancer cells results in loss of 1alpha,25-dihydroxyvitamin D3 responsiveness.
    Ting HJ; Bao BY; Reeder JE; Messing EM; Lee YF
    Mol Cancer Res; 2007 Sep; 5(9):967-80. PubMed ID: 17855664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the influence of vitamin D3 metabolites on apoptosis induction in human neoplastic cells.
    Gruber BM; Anuszewska EL
    Acta Pol Pharm; 2003; 60(5):363-6. PubMed ID: 15005419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcidiol [25(OH)D3]: from diagnostic marker to therapeutical agent.
    Brandi ML; Minisola S
    Curr Med Res Opin; 2013 Nov; 29(11):1565-72. PubMed ID: 24020910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of prostaglandin metabolism by calcitriol attenuates growth stimulation in prostate cancer cells.
    Moreno J; Krishnan AV; Swami S; Nonn L; Peehl DM; Feldman D
    Cancer Res; 2005 Sep; 65(17):7917-25. PubMed ID: 16140963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.